+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
Systemic Lupus Erythematosus - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 816 Pages
  • Global
From
From
From
From
From
From
From
Cerebral Palsy Treatment Market Report 2025 - Product Thumbnail Image

Cerebral Palsy Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Anticonvulsants Market Report 2025 - Product Thumbnail Image

Anticonvulsants Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Ataxia Market Report 2025 - Product Thumbnail Image

Ataxia Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Myasthenia Gravis Treatment Market Report 2025 - Product Thumbnail Image

Myasthenia Gravis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Rare Neurological Disease Treatment Market Report 2025 - Product Thumbnail Image

Rare Neurological Disease Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Grand Mal Seizure Treatment Market Report 2025 - Product Thumbnail Image

Grand Mal Seizure Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Loading Indicator